Azacitadine 200 mg Tablet

Azacitadine 200 mg Tablet Specification

Origin of Medicine
India

Indication
used in the treatment of some kinds of blood cancer

Pacakaging (Quantity Per Box)
14 Tablets

Dosage Form
Tablet

Salt Composition
Azacitadine

Drug Type
General Medicines

Ingredients
Azacitadine

Physical Form
Tablets

Function
Cancer Treatment

Dosage
200mg

Dosage Guidelines
As per doctor suggestion

Storage Instructions
Room temperature

Azacitadine 200 mg Tablet Trade Information

Minimum Order Quantity
100 Packs

Supply Ability
5000 Packs Per Month

Delivery Time
7 Days

Packaging Details
14 Tablets in a Bottle

Main Export Market(s)
Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa

Main Domestic Market
All India

About Azacitadine 200 mg Tablet

Azacitidine Brand names available in India?

Azacitidine is the generic name of the medication and is its international nonproprietary name. Azacitidine is marketed under the brand name Azatend among others.

Azacitidine, sold under the brand name Azatend among others, is a medication used for the treatment of myelodysplastic syndrome, myeloid leukemia, and juvenile myelomonocytic leukemia. It is a chemical analog of cytidine, a nucleoside in DNA and RNA. Azacitidine and its deoxy derivative, decitabine (also known as 5-aza-2Â-deoxycytidine) were first synthesized in Czechoslovakia as potential chemotherapeutic agents for cancer.

Azacitidine is indicated for the treatment of myelodysplastic syndrome, for which it received approval by the U.S. Food and Drug Administration (FDA) on 19 May 2004. Azacitidine is also indicated for the treatment of myeloid leukemia and juvenile myelomonocytic leukemia. The combination of azacitidine and venetoclax is also approved for AML.

Tell us about your requirement